Four years' experience of intravenous colomycin in an adult cystic fibrosis unit

European Respiratory Journal

Volumn 12, Issue 3, 1998, Pages 592-594

  Ledson, M J ^a   Gallagher, M J ^a   Cowperthwaite, C ^a   Convery, R P ^a   Walshaw, M J ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Colomycin sulphomethate; Cystic fibrosis; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PIPERACILLIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RASH; SPIROMETRY; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; COLISTIN; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; MALE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; TREATMENT OUTCOME;

EID: 0031657976     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12030592     Document Type: Article

References (19)

1. Fitzsimmonds SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1-9.
2. Cheng K, Smyth R, Govan J, et al. Spread of B-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996; 348: 639-642.
3. Mouton JW, Hollander J, Horrevorts AM. Emergence of antibiotic resistance amongst P. aeruginosa isolates from patients with cystic fibrosis. J Antimicrobial Chemother 1993; 31: 919-926.
4. Koyama Y, Kurosasa A, Tsuchiya A, Takakuta K. A new antibiotic "Colistin" produced by spore-forming soil bacteria. J Antibiot 1950; 3: 457-458.
5. Bergan T, Fuglesang J. Polymixin antibiotics. Chemical and pharmokinetic properties. Antibiot Chemother 1982; 31: 119-144.
6. David HL, Rastogi N. Antibacterial action of colomycin (polymixin E) against Mycobacterium aurum. Antimicrob Agents Chemother 1985; 27: 701-707.
7. Koike M. Iida K, Matsuo T. Electron microscopic studies on mode of action of polymixin. J Bacteriol 1969; 97: 448-452.
8. Fekety R. Polymixins. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles of Infective Diseases, 3rd edn. Edinburgh, Churchill Livingstone, 1990; pp. 323-325.
9. Hosseini H. Bacterial sensitivity to antibiotics. Curr Ther Res 1969; 11: 397-405.
10. Truant JP. A three-year survey of the antibacterial spectra of the more commonly used chemotheraputic agents. Can Med Ass J 1967; 96: 589-596.
11. Froman J, Gross L, Curatola S. Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals. J Urol 1970; 103: 210-214.
12. Price DJE, Graham DI. Effects of large doses of colistin sulphomethate on renal function. Br Med J 1970; 4: 525-527.
13. Koch-wester J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate: manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 1970; 72: 857-868.
14. Shale DJ. Predicting survival in cystic fibrosis. Thorax 1997; 52: 309.
15. Jusko WJ, Mosvich LL, Gerbracht LM, et al. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 1974; 56: 1038-1044.
16. Spiro M, Chai RP, Isles AF, et al. Cloxacillin absorption and disposition in cystic fibrosis. J Paediatr 1984; 105: 829-835.
17. Anwar H, Strap JL, Costeron JW. Establishment of aging biofilms: possible mechanisms of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother 1992; 36: 1347-1351.
18. Bosso JA, Liptak CA, Seilheimer DK, Harrison GM. Toxicity of colistin in cystic fibrosis patients. DICP Ann Pharmacother 1991; 25: 1168-1170.
19. Conway SP, Pond MN, Watson AJ, Etherington C, Robey HL, Goldman MH. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax 1997; 52: 987-993.